Evaluating the MobileLink Hip Prosthesis System Outcomes
Clinical and Functional Outcome of the MobileLink Acetabular Cup System in the Short-, Mid-, and Longterm Follow-up
This study is looking at how well the MobileLink hip replacement system works and how satisfied patients are after getting it.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 520 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Waldemar Link GmbH & Co. KG Industry-sponsored |
| Locations | 2 sites (Kiel and 1 other locations) |
| Trial ID | NCT04688593 on ClinicalTrials.gov |
What this trial studies
This observational study aims to collect clinical data on the MobileLink acetabular cup system used in hip replacement surgeries. It focuses on assessing the short-, mid-, and long-term outcomes of the prosthesis under routine conditions, including patient satisfaction. The study involves patients who have undergone implantation of the MobileLink system and will monitor their progress over time. The data collected will help understand the effectiveness and reliability of this hip prosthesis.
Who should consider this trial
Good fit: Ideal candidates are adults aged 18 and older who are undergoing implantation of the MobileLink acetabular cup system.
Not a fit: Patients requiring revision surgeries, those with a BMI of 40 kg/m² or higher, or individuals who cannot comply with study requirements will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could provide valuable insights into the long-term performance and patient satisfaction associated with the MobileLink hip prosthesis.
How similar studies have performed: Other studies on hip prosthesis systems have shown positive outcomes, indicating that this approach is supported by existing evidence.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Implantation of a MobileLink acetabular cup system and a femoral stem manufactured by Waldemar Link * Age ≥ 18 years * Fully signed patient informed cons Exclusion Criteria: * Revisions * Body Mass Index (BMI) ≥ 40 kg/m² * Patient who is foreseeable not able to understand the study and the study-related circumstances * Patients who is foreseeable non-compliant to the treatment and the follow-ups * Pregnant or breast-feeding women * Prisoner
Where this trial is running
Kiel and 1 other locations
- Lubinus Stiftung — Kiel, Germany (Recruiting)
- NHS FIFE Victoria Hospital — Kirkcaldy, United Kingdom (Recruiting)
Study contacts
- Study coordinator: Lisa Skottke, PhD
- Email: l.skottke@link-ortho.com
- Phone: +494053995673
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.